The results of a phase three clinical trial for a cholesterol-lowering drug have shown that this drug, called enlicitide, can reduce the levels of low-density lipoprotein (LDL) cholesterol by 60% compared to…
Continue Reading
News Source: www.labroots.com

Leave a Reply